Compound Summary
L-Methionine sulfoximine
Compound Information
L-Methionine sulfoximine
Compound Name: | L-Methionine sulfoximine |
Compound CID: | 89034 |
Synonyms: | L-Methionine sulfoximine 15985-39-4 (2S)-2-amino-4-(S-methylsulfonimidoyl)butanoic acid L-Methionine-S,R-sulfoximine L-Methionine R,S-Sulfoximine More... |
Iupac Name: | (2S)-2-amino-4-(methylsulfonimidoyl)butanoic acid |
InChI: | InChI=1S/C5H12N2O3S/c1-11(7,10)3-2-4(6)5(8)9/h4,7H,2-3,6H2,1H3,(H,8,9)/t4-,11?/m0/s1 |
InChIKey: | SXTAYKAGBXMACB-DPVSGNNYSA-N |
Canonical Smiles: | CS(=N)(=O)CCC(C(=O)O)N |
Isomeric Smiles: | CS(=N)(=O)CC[C@@H](C(=O)O)N |
Molecular Weight: | 180.23 |
Molecular Formula: | C5H12N2O3S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-Methionine sulfoximine
Molecular Weight: | 180.23 |
Molecular Formula: | C5H12N2O3S |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 11 |
Complexity: | 244 |
Synonyms
L-Methionine sulfoximine
| L-Methionine sulfoximine | L-Methionine sulfoximine |
|---|---|
L-Methionine sulfoximine |
15985-39-4 |
(2S)-2-amino-4-(S-methylsulfonimidoyl)butanoic acid |
L-Methionine-S,R-sulfoximine |
L-Methionine R,S-Sulfoximine |
L-Methionine-(S,R)-Sulfoximine |
Butanoic acid, 2-amino-4-(S-methylsulfonimidoyl)-, (2S)- |
UNII-DE3D2PZ3TT |
DE3D2PZ3TT |
Methionine sulfoximine (L) |
CHEBI:28490 |
UNII-M9P6YZ6JX9 |
L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine |
(2S)-2-Amino-4-(S-methylsufonimidoyl)butanoic acid |
MFCD00002621 |
2S-amino-4-(S-methylsulfonimidoyl)-butanoic acid |
L-Methionine S-Sulfoximine |
L-Methionine (R,S)-sulfoximine |
M9P6YZ6JX9 |
(2S)-2-AMINO-4-(METHYLSULFONIMIDOYL)BUTANOIC ACID |
UNII-7X87YR5KVS |
7X87YR5KVS |
L-Methionine-(S)-sulfoximine |
Prestwick_805 |
L-Methionine-Sulfoximine |
Prestwick0_000523 |
Prestwick1_000523 |
Prestwick2_000523 |
Prestwick3_000523 |
Lopac0_000797 |
BSPBio_000505 |
SCHEMBL187872 |
Methionine sulfoximine, (S)- |
SPBio_002426 |
BPBio1_000557 |
CHEMBL143324 |
CHEMBL1627202 |
Butanoic acid, 2-amino-4-(S-methylsufonimidoyl)-, (2S)- |
DTXSID30936181 |
HMS1569J07 |
HMS2096J07 |
HMS3262O16 |
BCP10104 |
Tox21_500797 |
AKOS015892783 |
CCG-204881 |
DB14103 |
LP00797 |
SDCCGSBI-0050774.P002 |
NCGC00094132-01 |
NCGC00094132-02 |
NCGC00094132-03 |
NCGC00094132-04 |
NCGC00094132-07 |
NCGC00261482-01 |
AS-40141 |
DS-018180 |
AB00513853 |
EU-0100797 |
AZ0001-0559 |
C03510 |
M 5379 |
A810076 |
SR-01000075995 |
J-009648 |
SR-01000075995-1 |
(2S)-2-Amino-4-(S-methylsufonimidoyl)-butanoic acid |
Q27103738 |
UNII-M9P6YZ6JX9 component QLMUQBNMEHYOAX-AQPAIEDISA-N |
UNII-M9P6YZ6JX9 component QLMUQBNMEHYOAX-AUIPBDMJSA-N |
(2S)-2-Amino-4-((S(S))-S-methylsulfonimidoyl)butanoic acid |
Butanoic acid, 2-amino-4-((S(S))-S-methylsulfonimidoyl)-, (2S)- |
L-Methionine sulfoximine, certified reference material, TraceCERT(R) |
L-Methionine sulfoximine, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production. |
Experimental Data
L-Methionine sulfoximine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 3.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
L-Methionine sulfoximine
Statistics Data
L-Methionine sulfoximine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 3.000000000000000 | 1 | 1 |
Statistics Data Visualization
L-Methionine sulfoximine
